GW Pharma denies supply issues with marijuana-based drug Epidiolex after stock falls
GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply…
News February 21GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply…
News February 21Marijuana Business Daily has launched its seventh annual survey of cannabis industry executives and investors, an undertaking that’s intended…
News February 12Auxly Cannabis Group, a vertically integrated marijuana company in Vancouver, British Columbia, said Thursday it is ending a…
News February 7Member states of the United Nations Commission on Narcotic Drugs (CND) received the World Health Organization Expert Committee on…
News January 31Hexo Corp., a licensed producer of cannabis based in Quebec, Canada, raised 57.6 million Canadian dollars ($43.7 million) Wednesday when…
News January 30Khiron Life Sciences, an integrated medical cannabis company with core operations in Colombia, has agreed to buy Uruguay’s…
News January 29The birth of the legal cannabis industry in Canada is akin to the gold rush, but very few…
News January 18A Canadian marijuana company will become the first “pure play” cannabis listing on a major U.S. stock market,…
News February 26Attorney General Jeff Sessions didn’t have hemp in mind when he repealed Obama-era protections for state-legal marijuana businesses.…
News January 16